CL2A-SN-38 DCA 1279680-68-0(free base)

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

CL2A-SN-38 是一种药物-接头缀合物，由有效的 DNA 拓扑异构酶 I 抑制剂 SN-38 和接头 CL2A 组成，用于制备抗体药物缀合物 (ADC)。

CL2A-SN-38 is a drug-linker conjugate composed of a potent a DNA Topoisomerase I inhibitor SN-38 and a linker CL2A to make antibody drug conjugate (ADC)..?CL2A-SN-38 is composed of a potent a DNA Topoisomerase I inhibitor SN-38 and a linker CL2A to make antibody drug conjugate (ADC).?CL2A-SN-38 provides significant and specific antitumor effects against a range of human solid tumor types.?CL2A is a noncleavable complicated PEG8- and triazole-containing PABC-peptide-mc linker.?CL2A is cleavable through pH sensitivity, giving rise to bystander effect, and binds the antibody at a cysteine residue via a disulfide bond.

——

——

——

Others

Other Targets

Others

——

——

——

1738.49

C77H101Cl4N11O26

>98% (HPLC)

——

OC(=O)C(Cl)Cl.OC(=O)C(Cl)Cl.CCc1c2Cn3c(cc4c(COC(=O)[C@@]4(CC)OC(=O)OCc4ccc(NC(=O)[C@H](CCCCN)NC(=O)COCC(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCn5cc(CNC(=O)C6CCC(CN7C(=O)C=CC7=O)CC6)nn5)cc4)c3=O)-c2nc2ccc(O)cc12

——

(-20℃)

With Ice Pack

≥ 2 years